Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
ProThera Biologics
Sort By
Newest First
1 / 1
1 / 1
Licensing Agreement
ProThera Biologics and Takeda Develop Novel Plasma-Derived Therapy Based on Inter-alpha Inhibitor Proteins
Takeda
PR-M04-20-NI-034
Apr 24, 2020
